Beta Bionics, Inc. (BBNX) stock
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.72−0.49 (-3.22%)
Close on Nov 17, 2026Market cap $800.28MP/E –Yield –
Beta Bionics total assets
Total assets on the balance sheet at the end of each period.
Beta Bionics's total assets was $443.76M at Sep 30, 2026. For fiscal 2025 it was $328.74M, up 119.7% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $328.74M | +119.7% |
| FY2024 | Dec 31, 2024 | $149.65M | +36.0% |
| FY2023 | Dec 31, 2023 | $110.04M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $443.76M | +34.5% |
| Q2 FY2026 | Jun 30, 2026 | $292.39M | -11.4% |
| Q1 FY2026 | Mar 31, 2026 | $304.42M | -9.9% |
| Q4 FY2025 | Dec 31, 2025 | $328.74M | +119.7% |
| Q3 FY2025 | Sep 30, 2025 | $330.05M | +199.9% |
| Q2 FY2025 | Jun 30, 2025 | $329.97M | – |
| Q1 FY2025 | Mar 31, 2025 | $338.02M | – |
| Q4 FY2024 | Dec 31, 2024 | $149.65M | – |
| Q4 FY2023 | Dec 31, 2023 | $110.04M | – |
See a number that looks wrong?